Uploaded December 2022 | Updated September 2026, 1 week ago
Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravelled molecular secrets hidden in cancers using PandaOmics, an AI-driven target discovery platform. The team explored gene expression changes in rare DNA repair-deficient disorders to identify novel cancer targets. The findings provide important insights on the path to developing personalized cancer therapies.
To read the full paper: nature.com/articles/s41419-022-05437-w?utm_campaign=related_content&utm_source=BIOENG&utm_medium=communities
To learn more about the collaboration: bioengineeringcommunity.nature.com/posts/a-global-collaboration-in-precision-oncology-and-dna-repair-disorders-between-the-university-of-copenhagen-insilico-medicine-and-the-university-of-chicago-enabled-by-pandaomics-artificial-intelligence-engine
Researchers from Insilico Medicine, University of Copenhagen, and University of Chicago unravelled molecular secrets hidden in cancers using PandaOmics, an AI-driven target discovery platform. The team explored gene expression changes in rare DNA repair-deficient disorders to identify novel cancer targets. The findings provide important insights on the path to developing personalized cancer therapies.
To read the full paper: nature.com/articles/s41419-022-05437-w?utm_campaign=related_content&utm_source=BIOENG&utm_medium=communities
To learn more about the collaboration: bioengineeringcommunity.nature.com/posts/a-global-collaboration-in-precision-oncology-and-dna-repair-disorders-between-the-university-of-copenhagen-insilico-medicine-and-the-university-of-chicago-enabled-by-pandaomics-artificial-intelligence-engine
